tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CMPX Stock Latest News

Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress
Company AnnouncementsCompass Therapeutics Reports Q3 2024 Financials and Clinical Progress
13h ago
CMPX
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
PremiumThe Fly
Compass Therapeutics price target raised to $7 from $5 at Ladenburg
1d ago
CMPX
Compass Therapeutics reports Q3 EPS (8c), consensus (11c)
PremiumThe Fly
Compass Therapeutics reports Q3 EPS (8c), consensus (11c)
2d ago
CMPX
Compass Therapeutics sees cash runway into 1Q27
PremiumThe Fly
Compass Therapeutics sees cash runway into 1Q27
2d ago
CMPX
Compass Therapeutics presents biomarker data related to CTX-471
PremiumThe Fly
Compass Therapeutics presents biomarker data related to CTX-471
6d ago
CMPX
Compass Therapeutics upgraded to Buy from Neutral at Ladenburg
PremiumThe FlyCompass Therapeutics upgraded to Buy from Neutral at Ladenburg
2M ago
CMPX
Compass Therapeutics files $300M mixed securities shelf
Premium
The Fly
Compass Therapeutics files $300M mixed securities shelf
3M ago
CMPX
Compass Therapeutics reports Q2 EPS (10c), consensus (9c)
Premium
The Fly
Compass Therapeutics reports Q2 EPS (10c), consensus (9c)
3M ago
CMPX
Compass Therapeutics completes patient enrollment in COMPANION-002
PremiumThe Fly
Compass Therapeutics completes patient enrollment in COMPANION-002
3M ago
CMPX
Compass Therapeutics Announces CEO Transition and New Leadership
PremiumCompany Announcements
Compass Therapeutics Announces CEO Transition and New Leadership
6M ago
8K
CMPX
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
PremiumThe Fly
Compass Therapeutics CEO Vered Bisker-Leib steps down, Thomas Schuetz succeeds
6M ago
CMPX
Compass Therapeutics sees cash runway into late 2026
PremiumThe Fly
Compass Therapeutics sees cash runway into late 2026
6M ago
CMPX
Compass Therapeutics reports Q1 EPS (8c), consensus (11c)
PremiumThe FlyCompass Therapeutics reports Q1 EPS (8c), consensus (11c)
6M ago
CMPX
CMPX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CMPX Upcoming Earnings Report: What to Expect?
6M ago
CMPX
Compass Therapeutics receives FDA FTD for investigation of CTX-009
Premium
The Fly
Compass Therapeutics receives FDA FTD for investigation of CTX-009
7M ago
CMPX
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
PremiumCompany Announcements
Compass Therapeutics’ CTX-009 Gains FDA Fast Track Status
7M ago
8K
CMPX
Compass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
PremiumThe Fly
Compass Therapeutics announces first patient dosed in Phase 1 study of CTX-8371
7M ago
CMPX
Compass Therapeutics presents data on combination of CTX-009, CTX-471
PremiumThe Fly
Compass Therapeutics presents data on combination of CTX-009, CTX-471
7M ago
CMPX
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
PremiumThe Fly
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
8M ago
CMPX
Compass Therapeutics announces publication of CTX-8371 preclinical data
PremiumThe FlyCompass Therapeutics announces publication of CTX-8371 preclinical data
9M ago
CMPX
CMPX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CMPX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
CMPX
Compass Therapeutics provides business update
Premium
The Fly
Compass Therapeutics provides business update
10M ago
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >